Hemogenyx Pharmaceuticals Plc (LON:HEMO)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 620.00
-20.00 (-3.13%)
Nov 4, 2026, 4:22 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 42.16 million as of November 4, 2026. It is the 28,785th most valuable company in the world and the 640th biggest in the United Kingdom. Its market cap has decreased by 5.03% in one year.
Market Cap
42.16M
Enterprise Value
39.38M
Revenue
n/a
Global Rank
Country Rank
#640 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 42.16M, an increase of 294.71%. That is a compound annual growth rate of 16.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 41.14M | 19.05% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 107.06M |
| Scancell Holdings | 106.68M |
| 4basebio | 81.62M |
| Faron Pharmaceuticals Oy | 68.03M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 48.10M |
| Arecor Therapeutics | 38.51M |
| IXICO | 30.66M |